Updated Jul 16, 2026
Jayaraman Vivek K has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $567K.
Jayaraman Vivek K is associated with Cerus Corporation, a company focused on blood safety and pathogen reduction technologies. Specific details about his role and contributions to the company are currently limited.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CERS | CERUS CORP | A — Grant or award | 554.5K | $0.00 | |
| 2026-07-02 | CERS | CERUS CORP | S — Open-market sale | 42.4K | $2.94 | $125K |
| 2026-07-02 | CERS | CERUS CORP | A — Grant or award | 80.0K | $0.00 | |
| 2026-06-02 | CERS | CERUS CORP | S — Open-market sale | 16.7K | $3.00 | $50K |
| 2026-05-05 | CERS | CERUS CORP | S — Open-market sale | 16.7K | $3.00 | $50K |
| 2026-03-16 | CERS | CERUS CORP | S — Open-market sale [10b5-1] | 165.2K | $1.66 | $274K |
| 2026-03-10 | CERS | CERUS CORP | S — Open-market sale [10b5-1] | 34.1K | $2.01 | $68K |
| 2026-03-10 | CERS | CERUS CORP | A — Grant or award [10b5-1] | 80.3K | $0.00 | |
| 2026-03-05 | CERS | CERUS CORP | A — Grant or award | 420.0K | $0.00 |
Jayaraman Vivek K is associated with Cerus Corporation, a company focused on blood safety and pathogen reduction technologies. Specific details about his role and contributions to the company are currently limited.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($567K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jayaraman Vivek K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.